Trilogy Capital’s Avantis Emerging Markets Equity ETF AVEM Stock Holding History
Bought
Maintained
Sold
Other funds holding AVEM
Trilogy Capital's AVEM Position: Q3 2026 in Review
Trilogy Capital reduced its Avantis Emerging Markets Equity ETF (AVEM) stake by 6% in Q3 2026, selling an estimated $153K and leaving 25,678 shares worth $2.41M. The position accounts for 0.09% of the portfolio, ranked #149.
Trilogy Capital first reported a position in AVEM in Q3 2022 and has held it in 17 quarters since. The position peaked at $15.9M in Q3 2024. 262 funds tracked by Wall St. Rank hold AVEM as of Q3 2026.
- Trilogy Capital held 25,678 shares of Avantis Emerging Markets Equity ETF worth $2.41M as of Q3 2026.
- Trilogy Capital sold 1,650 Avantis Emerging Markets Equity ETF shares in Q3 2026, an estimated $153K.
- Avantis Emerging Markets Equity ETF made up 0.09% of Trilogy Capital's portfolio in Q3 2026, its #149 holding.
- Trilogy Capital first reported a position in Avantis Emerging Markets Equity ETF in Q3 2022 and has held it in 17 quarters since.
- Trilogy Capital's Avantis Emerging Markets Equity ETF position peaked at $15.9M in Q3 2024.
- 262 funds tracked by Wall St. Rank held Avantis Emerging Markets Equity ETF as of Q3 2026.
Based on Trilogy Capital's 13F filing for Q3 2026, filed 20 Oct 2026.